Proprietary Hemp Based CBD Wellness Products & More

In today's competitive cannabis market Canada's 1933 Industries is an innovator in the sector. Boasting a vertically integrated business model encompa …

1933 Industries cannabis market

A Cannabis Market Innovator

In today's competitive cannabis market Canada's 1933 Industries is an innovator in the sector. Boasting a vertically integrated business model encompassing cultivation, production of THC products, manufacturing proprietary hemp based CBD wellness products with wide distribution across the United States. Next up, Cultivation expansion in Nevada, hemp processing and increased market penetration of CBD products into international markets. Committed to growth.

1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, they own licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence.

The Company owns 91% of Alternative Medicine Association and 100% of both Infused MFG. and Spire Global Strategy.

Investment Highlights

  • Fully integrated medical and adult-use licensee in Nevada
  • Owns and operates advanced cultivation facilities producing premium quality cannabis and hand-crafted products
  • White-label production under licensing agreements
  • Distribution to large dispensary network in Nevada
  • Verticals in hemp and CBD, from extraction to production of proprietary product line
  • Strong sales from hemp-based, CBD products to leading dispensaries in California
  • Growth-focused via asset acquisition in several US states and Canada

For more information on 1933 Industries Inc. (TGIF:CSE, TGIFF:OTCQX) please fill out the form below.

No items found.

You might also like

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs
Life Sciences
August 28, 2026

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
August 27, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
August 27, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info